Quality by Design and Operational Excellence in Pharmaceutical R&D: A Systematic Literature Review of Lean Six Sigma Integration
Downloads
Quality by Design (QbD), established through the International Council for Harmonisation (ICH) Q8(R2), Q9, and Q10 guidelines, provides a science-based framework for proactive quality assurance. Lean and Six Sigma, collectively referred to as Lean Six Sigma (LSS), offer complementary methodologies for waste elimination and process variability reduction, respectively. This systematic literature review critically analyzes the theoretical foundations and empirical evidence supporting the integration of QbD with Lean Six Sigma in pharmaceutical R&D, identifies methodological gaps in existing research, and proposes a conceptual direction for an integrated operational excellence framework. Following the PRISMA 2020 guidelines, a systematic search was conducted across the Scopus, PubMed, and ResearchGate databases using predefined inclusion and exclusion criteria. Studies published between 2015 and 2026 were considered. Twelve articles met the full eligibility criteria and were included in the final synthesis. All included studies demonstrated the strategic and operational compatibility of QbD with Lean and Six Sigma methodologies. The primary integration mechanisms identified were Design of Experiments (DoE), Failure Mode and Effects Analysis (FMEA), process capability indices (Cp and Cpk), and structured problem-solving methodologies, including Define, Measure, Analyze, Improve, and Control (DMAIC) and Design for Six Sigma (DFSS). Reported benefits included reduced batch failures, shorter development cycles, improved regulatory compliance, and measurable cost savings. However, a significant research gap was identified: none of the reviewed studies proposed a formal, validated, end-to-end integrated framework that operationalizes QbD and Lean Six Sigma throughout the entire pharmaceutical R&D lifecycle. The integration of QbD with Lean and Six Sigma is theoretically coherent and empirically supported. The primary opportunity for novelty in this field lies in developing and validating a unified framework that embeds LSS operational tools within the regulatory structure of QbD across all stages of pharmaceutical R&D.
al., S. Y. et. (2025). Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications,. https://doi.org/10.3390/pharmaceutics17050623
Alifiya, F., Chairun Wiedyaningsih, C., & Bondan Ardiningtyas, B. (2025). Productivity Improvement Through Lean Six Sigma In Pharmaceutical Manufacturing: A Narrative Review. Majalah Farmaseutik, 21(3), 302. https://doi.org/10.22146/FARMASEUTIK.V21I3.104946
Alifiya, F., & Fadilla, A. (2025). Overcoming Regulatory Barriers: A Narrative Review of Implementation Strategies and Cultural Challenges of Lean Six Sigma in a GMP Environment,. https://doi.org/10.63004/SNSMED.V4I2.885
Byrne, B., McDermott, O., & Noonan, J. (2021a). Applying lean six sigma methodology to a pharmaceutical manufacturing facility: A case study. Processes, 9(3). https://doi.org/10.3390/pr9030550
Byrne, B., McDermott, O., & Noonan, J. (2021b). Applying lean six sigma methodology to a pharmaceutical manufacturing facility: A case study,. https://doi.org/10.3390/pr9030550
Dahmash, E. Z., Al-Khattawi, A., Iyire, A., Al-Yami, H., Dennison, T. J., & Mohammed, A. R. (2018). Quality by Design (QbD) based process optimisation to develop functionalised particles with modified release properties using novel dry particle coating technique. PLoS ONE, 13(11), 1–20. https://doi.org/10.1371/journal.pone.0206651
Goswami, J. A., Modi, Z. M., Patel, K., & Patel, C. N. (2024). Review on Implementation of Quality by Design. International Journal of Innovative Science and Research Technology, 9(2), 544–548.
Grangeia, H. B., Silva, C., Simões, S. P., & Reis, M. S. (2019). Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives,. https://doi.org/10.1016/j.ejpb.2019.12.007
Grangeia, H. B., Silva, C., Simões, S. P., & Reis, M. S. (2020). Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. European Journal of Pharmaceutics and Biopharmaceutics, 147, 19–37. https://doi.org/10.1016/j.ejpb.2019.12.007
Hee, K. (2022). ??? ?? ?? ?? ??? ( QbD ) ? ?? QbD 6??? ?? ??? ?? ?? A Study on the Build of a QbD Six Sigma System to Promote Quality Improvement ( QbD ) Based on Drug Design. 50(3), 373–386.
Junker, B., Kosinski, M., Geer, D., Mahajan, R., Chartrain, M., Meyer, B., Dephillips, P., Wang, Y., Henrickson, R., Ezis, K., & Waskiewicz, M. (2015). Quality-by-Design Framework Design-for-Six-Sigma for Development of a Bioprocess Design-for-Six-Sigma for Development of a Bioprocess Quality-by-Design Framework. Journal.Pda.Org Downloaded From. https://doi.org/10.5731/pdajpst.2011.00739
Kholil, M., Haekal, J., Suparno, A., Oktaandhini, D. S., & Widodo, T. (2021a). Lean Six sigma Integration to Reduce Waste in Tablet coating Production with DMAIC and VSM Approach in Production Lines of Manufacturing Companies. International Journal Of Scientific Advances, 2(5), 719–726. https://doi.org/10.51542/ijscia.v2i5.8
Kholil, M., Haekal, J., Suparno, A., Oktaandhini, D. S., & Widodo, T. (2021b). Lean Six sigma Integration to Reduce Waste in Tablet coating Production with DMAIC and VSM Approach in Production Lines of Manufacturing Companies,. https://doi.org/10.51542/ijscia.v2i5.8
Kim, K. H., & Kim, H. (2022a). A Study on the Build of a QbD Six Sigma System to Promote Quality Improvement(QbD) Based on Drug Design. Journal of Korean Society for Quality Management, 50(3), 373–386. https://doi.org/10.7469/JKSQM.2022.50.3.373
Kim, K. H., & Kim, H. (2022b). A Study on the Build of a QbD Six Sigma System to Promote Quality Improvement(QbD) Based on Drug Design,. https://doi.org/10.7469/JKSQM.2022.50.3.373
Kusumawardani, R., & Widyatmoko, A. A. (2024). Enhancing Pharma Manufacturing Efficiency: Integrating Lean Six Sigma and Fuzzy FMEA for Waste Reduction,. https://doi.org/10.12928/si.v22i2.199
Prajapati, P. B., Patel, A., & Shah, S. A. (2021). Risk and DoE-Based DMAIC Principle to the Multipurpose-RP-HPLC Method for Synchronous Estimation of Anti-Hypertensive Drugs Using AQbD Approach. Journal of AOAC International, 104(5), 1442–1452. https://doi.org/10.1093/jaoacint/qsab079
Pramod, K., Tahir, M. A., Charoo, N. A., Ansari, S. H., & Ali, J. (2016). Pharmaceutical product development: A quality by design approach,. https://doi.org/10.4103/2230-973X.187350
Tamalika, T., Azhari, & Maryadi, D. (2025). Unpacking Lean Six Sigma Practice: A Systematic Literature Review of Performance Outcomes and Implementation Challenges (2020–2025),. https://doi.org/10.37477/ISEJOU.V4I1.860
Yang, S., Hu, X., Zhu, J., Zheng, B., Bi, W., Wang, X., Wu, J., Mi, Z., & Wu, Y. (2025). Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications. Pharmaceutics, 17(5), 1–24. https://doi.org/10.3390/pharmaceutics17050623
Copyright (c) 2026 Revinta Kurnia Septanti, Akbar Adhiutama
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
